235 evolution "https:" "https:" "https:" "https:" "https:" "Here We Are" positions at University of London
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
at RVC. The role You will support the development and optimisation of metaviromic and pathogen-targeted sequencing workflows for wildlife and domestic animal samples, contributing to the characterisation
-
About the role This role supports a multidisciplinary programme investigating the role of the Maresins, a family of pro-resolving lipid mediators, in early cancer development. You will process
-
About the Role You will drive the development of optical instrumentation that will accelerate the way printed perovskite photovoltaics are analysed and developed. You will design, build, and
-
the application there is ‘supporting statements’ section. If you add content here, we would like to see candidates’ own writing skills and discourage the use of AI for this purpose. We particularly welcome
-
commercial clinical activities and service development. Monitor hospital performance against financial, operational and caseload targets, ensuring effective financial control, cost management and resource
-
of theme performance, contribution to report and publication development, and support for communication, dissemination and engagement activities across the BRC delivery partnership and wider audiences. About
-
involves oversight of theme performance, contribution to report and publication development, and support for communication, dissemination and engagement activities across the BRC delivery partnership and
-
. The goals are to develop a greater understanding of basic mechanisms of immunological protection versus pathology, and to apply this knowledge to the development of interventions and the identification
-
About the Role The post-holder will investigate the role of the extracellular matrix (ECM) during the evolution of drug resistance in ovarian cancer. The ovarian cancer tumour microenvironment (TME
-
that our research is focused on where it is most needed. Using our linked health and molecular patient data we will drive the development and targeted prescription of treatments based on patients’ needs